Unum Therapeutics Inc. | 200 Cambridge Park Drive Suite 3100 | Cambridge, MA 02140  USA

Tel. +1.617.945.5576 | Email: info@unumrx.com

  • LinkedIn - White Circle
  • Twitter - White Circle

© Copyright 2014-2019 Unum Therapeutics

March 02, 2018

Unum Therapeutics Announces Appointment of Christiana Stamoulis to Additional Role of President

Unum Therapeutics Appoints Christiana Stamoulis to Additional Role of President

March 02, 2018

Unum Therapeutics Expands Board with Appointment of Two Additional Directors

Unum Therapeutics today announced the appointment of Karen J. Ferrante, MD, and Robert J. Perez to its Board of Directors.

November 01, 2017

Unum Therapeutics Announces Presentation of Initial Clinical Data from the ATTCK-20-2 Trial and Pre-Clinical Data on its Antibody-Coupled T Cell Receptor (ACTR) Platform

Unum Therapeutics Announces Presentation of Initial Clinical Data from the ATTCK-20-2 Trial and Pre-Clinical Data on its Antibody-Coupled T Cell Receptor (ACTR) Platform at the Upcoming 59th American Society of Hematology (ASH) Annual Meeting

October 27, 2017

Unum Therapeutics to Present New Data on its Antibody-Coupled T Cell Receptor (ACTR) Platform at the 2017 AACR-NCI-EORTC International Conference

Unum Therapeutics to Present New Data on its Antibody-Coupled T Cell Receptor (ACTR) Platform at the 2017 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

August 23, 2017

Unum Therapeutics Announces Active Investigational New Drug (IND) Application for ACTR087 in Combination with SEA-BCMA in Patients with Relapsed/Refractory Multiple Myeloma

Unum Therapeutics Announces Active Investigational New Drug (IND) Application for ACTR087 in Combination with SEA-BCMA in Patients with Relapsed/Refractory Multiple Myeloma.

August 14, 2017

Unum Therapeutics to Present at Wedbush PacGrow Healthcare Conference

Unum Therapeutics will present at the Wedbush PacGrow Healthcare Conference on Wednesday, August 16, 2017 at 1:55 pm ET. The conference is being held August 15-16, 2017 at the Le Parker Meridien in New York.

June 19, 2017

Unum Therapeutics Announces Active Investigational New Drug (IND) Application for ACTR707 in Combination with Rituximab in Patients with Relapsed/Refractory B-cell Lymphoma

Unum Therapeutics Announces Active Investigational New Drug (IND) Application for ACTR707 in Combination with Rituximab in Patients with Relapsed/Refractory B-cell Lymphoma.

May 09, 2017

Unum Therapeutics to Present Data on its Antibody-Coupled T Cell Receptor (ACTR) Platform at the Upcoming Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT)

Unum Therapeutics to Present Data on its Antibody-Coupled T Cell Receptor (ACTR) Platform at the Upcoming Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT)

April 03, 2017

Unum Therapeutics to Present New Data on its Antibody-Coupled T Cell Receptor (ACTR) Platform at the Upcoming American Association for Cancer Research (AACR) 2017 Annual Meeting

Unum Therapeutics announced that the Company has been selected for two poster presentations on its Antibody-Coupled T cell Receptor (ACTR) platform at the AACR 2017 Annual Meeting, which is being held in Washington DC, April 1-5, 2017.

February 27, 2017

Unum Therapeutics to Present at the Cowen and Company 37th Annual Health Care Conference

Unum Therapeutics announced that President and Chief Executive Officer Chuck Wilson will present at the Cowen and Company 37th Annual Health Care Conference on March 6, 2017 at 4:00pm ET.

Please reload